Unknown

Dataset Information

0

Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins.


ABSTRACT: We describe a facile method to activate or repress transcription of endogenous genes in a quantitative and specific manner by treatment with designed regulatory proteins (DRPs), in which artificial transcription factors (ATFs) are fused to cell-penetrating peptides (CPPs). Penetration of DRPs into cells is mediated by an N-terminal CPP fused to a nuclear localization signal; a DNA-binding domain and a transactivation domain follow. The DNA-binding domain was targeted to the vascular endothelial growth factor (VEGF)-A gene. An agonist DRP was rapidly taken up by cells and transported to the nucleus; soon after, the cells began transcribing the gene and secreting VEGF-A protein in a dose-dependent manner. Multiple copies of a short oligopeptide derived from a minimal transactivation domain of human beta-catenin was stronger than VP-16. The SRDX domain from the plant transcription factor, SUPERMAN, changed the DRP to a hypoxia-induced antagonist of VEGF-A. DRPs combine many of the potential benefits of transgenes with those of recombinant proteins.

SUBMITTER: Tachikawa K 

PROVIDER: S-EPMC523457 | biostudies-literature | 2004 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins.

Tachikawa Kiyoshi K   Schröder Oliver O   Frey Gerhard G   Briggs Steven P SP   Sera Takashi T  

Proceedings of the National Academy of Sciences of the United States of America 20041008 42


We describe a facile method to activate or repress transcription of endogenous genes in a quantitative and specific manner by treatment with designed regulatory proteins (DRPs), in which artificial transcription factors (ATFs) are fused to cell-penetrating peptides (CPPs). Penetration of DRPs into cells is mediated by an N-terminal CPP fused to a nuclear localization signal; a DNA-binding domain and a transactivation domain follow. The DNA-binding domain was targeted to the vascular endothelial  ...[more]

Similar Datasets

| S-EPMC3936796 | biostudies-literature
| S-EPMC6992714 | biostudies-literature
| 8689 | ecrin-mdr-crc
| S-EPMC2151583 | biostudies-literature
| S-EPMC7344169 | biostudies-literature
| S-EPMC4510616 | biostudies-literature
| S-EPMC155226 | biostudies-literature
| S-EPMC6391025 | biostudies-literature
| S-EPMC6894551 | biostudies-literature
| S-EPMC10740153 | biostudies-literature